Blood management in a patient
Blood administration in a affected person with anti-Okay a antibody who underwent cardiac surgical procedure utilizing cardiopulmonary bypass: a case report
Background: The Cardiac surgical procedure underneath cardiopulmonary bypass (CPB) is commonly related to huge bleeding and blood transfusion. For sufferers requiring particular blood merchandise, meticulous blood administration is vital to cut back blood loss, in addition to the necessity for transfusion. Right here, now we have described the intraoperative blood administration in a affected person with anti-Okaya antibody, who underwent cardiac surgical procedure with CPB.
Case presentation: A 79-year-old girl was scheduled for open aortic valve substitute and tricuspid valve annuloplasty underneath hypothermic CPB. Her blood kind was A RhD(+) Okay(a-), and anti-Okaya, an especially uncommon antibody towards erythrocyte antigen, was detected. Eight models of Okay(a-) frozen thawed pink cells (FTRCs), and 6 models of pink blood cells donated by three Okay(a-) people had been collected simply previous to surgical procedure.
Though she was anemic, acute normovolemic hemodilution was carried out after anesthesia induction to protect the autologous complete blood. 4 models of FTRCs had been loaded within the CPB priming answer, and modified ultrafiltration was adopted throughout CPB to stop additional hemodilution. After CPB termination, two models of FTRCs, 4 models of recent frozen plasma, and ten models of platelet focus had been intensively transfused, facilitating surgical hemostasis and secure hemodynamics
. The autologous complete blood was returned to the affected person within the intensive care unit. Because the hemoglobin and hematocrit ranges had been maintained postoperatively, no further transfusion was required all through her hospital keep.
Conclusions: Multidisciplinary intraoperative blood administration in a affected person with anti-Okaya antibody facilitated profitable cardiac surgical procedure utilizing CPB, together with efficient use of restricted blood merchandise.
Recombinant Human LEC (CCL16) |
|||
Z100329 | ABM | 1.0 mg | EUR 3900 |
Description: CCL16 is a CC chemokine that specifically attracts lymphocytes, dendritic cells, and monocytes; increases their adhesive properties and has myelosuppressive activity. It is constitutively expressed in liver and is increased by interleukin 10 (IL-10) in activated monocytes. CCL16 is present in human plasma suggesting that it may be active outside hepatic tissue. CCR1, CCR2, CCR5, and CCR8 are the functional receptors of this chemokine. |
Anti-Human LEC Goat Polyclonal Antibody |
|||
TA328365 | Origene Technologies GmbH | 100 µg | Ask for price |
Human LEC/CCL16 Antibody Pair Set |
|||
ABPR-ZB293 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
Description: Quantitative determination of Human LEC/CCL16 |
LEC antibody |
|||
10R-L115A | Fitzgerald | 500 ug | EUR 240 |
|
|||
Description: Mouse monoclonal LEC antibody |
LEC antibody |
|||
70R-LG003 | Fitzgerald | 50 ug | EUR 312 |
|
|||
Description: Affinity purified Goat polyclonal LEC antibody |
LEC/NCC-4 Human Recombinant |
|||
rAP-0241 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human LEC (CCL16) Protein |
|||
PROTO15467-1 | BosterBio | 20ug | EUR 380.4 |
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
Biotinylated Anti-Human LEC Goat Polyclonal Antibody |
|||
TA328364 | Origene Technologies GmbH | 50 µg | Ask for price |
Human LEC Recombinant Protein Lyophilized |
|||
IHULECRLY5UG | Innovative research | each | EUR 341 |
|
|||
Description: Human LEC Recombinant Protein Lyophilized |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
7-01792 | CHI Scientific | 5µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
7-01793 | CHI Scientific | 20µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
7-01794 | CHI Scientific | 1mg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
HECCP-1601 | Cyagen | 5ug | Ask for price |
LEC protein |
|||
30R-AL013 | Fitzgerald | 20 ug | EUR 312 |
|
|||
Description: Purified recombinant Human LEC protein |
LEC Chemokine(LEC66) Antibody |
|||
BNC040066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC040066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC040067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC040067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC810066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC810066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC810067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC810067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC940066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC940066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC940067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC940067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC880066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC880066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC880067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC880067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC430066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC430066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC430067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC430067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC050066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC050066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC050067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC050067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC470066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC470066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC470067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC470067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC400066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC400066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC400067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC400067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC550066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC550066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC550067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC550067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC610066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC610066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC610067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC610067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC800066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC800066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC800067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC800067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC700066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC700066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC700067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC700067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC680066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC680066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC680067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC680067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCP0066-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC66), PerCP conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCP0067-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC67), PerCP conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCR0066-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC66), RPE conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCR0067-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC67), RPE conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNUB0066-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNUB0066-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNUB0067-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNUB0067-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCA0066-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC66), APC conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCA0067-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC67), APC conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCAP0066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCAP0066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCAP0067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCAP0067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCB0066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCB0066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
Intramolecular Photoelectrochemical System Utilizing Tyrosine-Modified Antibody-Focused Peptide as Electron Donor for Detection of Biomarkers
An intramolecular photoelectrochemical (PEC) system is designed from the novel electron donor YYYHWRGWV (Y3-H) peptide ligand for the primary time. The bifunctional nonapeptide can’t solely depend on the HWRGWV sequence as a site-oriented immobilizer to acknowledge the crystallizable fragment (Fc) domains of the antibody but additionally acts as electron donors for PEC technology through three tyrosine (Y) of the N-terminal.
The Bi2WO6/AgInS2 heterojunction with a major visible-light absorption is utilized as a photoelectric generator, and the motivation is ascribed to a confirmed proposition, specifically, that short-wavelength illuminant radiates proteins, inflicting a decline in bioactivity of immune protein.
An modern biosensor is fabricated utilizing the above methods for the detection of CYFRA21-1, a biomarker of squamous cell lung carcinoma. This kind of PEC-based sensing platform reveals convincing experimental information and might be an efficient candidate for medical software sooner or later attributable to their extraordinarily skillful conception.
Antibodies from A number of Sclerosis Mind Recognized Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Acknowledged by Oligoclonal Bands
A number of sclerosis (MS) is a continual inflammatory demyelinating illness of the central nervous system (CNS), the etiology of which is poorly understood. The commonest laboratory abnormality related to MS is elevated intrathecal immunoglobulin G (IgG) synthesis and the presence of oligoclonal bands (OCBs) within the mind and cerebrospinal fluid (CSF).
Nonetheless, the most important antigenic targets of those antibody responses are unknown. The chance of MS is elevated after infectious mononucleosis (IM) attributable to EBV an infection, and MS sufferers have larger serum titers of anti-EBV antibodies than management populations. Our purpose was to determine disease-relevant epitopes of IgG antibodies in MS; to take action, we screened phage-displayed random peptide libraries (12-mer) with whole IgG antibodies purified from the mind of a affected person with acute MS.
We recognized and characterised the phage peptides for binding specificity to intrathecal IgG from sufferers with MS and from controls by ELISA, phage-mediated Immuno-PCR, and isoelectric focusing.
We recognized two phage peptides that share sequence homologies with EBV nuclear antigens 1 and a couple of (EBNA1 and EBNA2), respectively. The specificity of the EBV epitopes discovered by panning with MS mind IgG was confirmed by ELISA and aggressive inhibition assays.
Utilizing a extremely delicate phage-mediated immuno-PCR assay, we decided particular bindings of the 2 EBV epitopes to IgG from CSF from 46 MS and 5 inflammatory management (IC) sufferers. MS CSF IgG have considerably larger bindings to EBNA1 epitope than to EBNA2 epitope, whereas EBNA1 and EBNA2 didn’t considerably differ in binding to IC CSF IgG.
Additional, the EBNA1 epitope was acknowledged by OCBs from a number of MS CSF as proven in blotting assays with samples separated by isoelectric focusing. The EBNA1 epitope is reactive to MS intrathecal antibodies equivalent to oligoclonal bands.
This reinforces the potential function of EBV within the etiology of MS. Graphical summary Antibodies purified from an MS mind plaque had been panned by phage show peptide libraries to discern potential antigens. Phage displaying peptide sequences resembling Epstein-Barr Virus Nuclear Antigens 1 & 2 (EBNA1 & 2) epitopes had been recognized. Antibodies from sera and CSF from different MS sufferers additionally reacted to these epitopes.
Recombinant Human BRAK (CXCL14) |
|||
7-01785 | CHI Scientific | 1mg | Ask for price |
CXCL14/BRAK, human recombinant |
|||
4278-10 | Biovision | each | EUR 288 |
CXCL14/BRAK, human recombinant |
|||
4278-1000 | Biovision | each | EUR 3348 |
CXCL14/BRAK, human recombinant |
|||
4278-50 | Biovision | each | EUR 705.6 |
Recombinant Human CXCL14 (BRAK) |
|||
Z102375 | ABM | 20 µg | EUR 195 |
Description: Chemokine (CXC motif) ligand 14, also known as breast and kidney-expressed chemokine (BRAK), is a CXC chemokine that is a potent chemoattractant for neutrophils but not for T-cells, B-cells, monocytes or granulocytes. Mature CXCL14 has many conserved features of the CXC family and is 30% homologous to the MIP-α and MIP-β sequences, but differs in that it has an additional five amino acid sequence in between the third and fourth cysteines and a short N-terminus. It is usually highly expressed near its fibroblast source and in epidermal fibroblasts and keratinocytes of skin, but is absent from cancer cells. |
Recombinant Human CXCL14 (BRAK) |
|||
Z102379 | ABM | 1.0 mg | EUR 3900 |
Description: Chemokine (CXC motif) ligand 14, also known as breast and kidney-expressed chemokine (BRAK), is a CXC chemokine that is a potent chemoattractant for neutrophils but not for T-cells, B-cells, monocytes or granulocytes. Mature CXCL14 has many conserved features of the CXC family and is 30% homologous to the MIP-α and MIP-β sequences, but differs in that it has an additional five amino acid sequence in between the third and fourth cysteines and a short N-terminus. It is usually highly expressed near its fibroblast source and in epidermal fibroblasts and keratinocytes of skin, but is absent from cancer cells. |
BRAK (CXCL14) Human Recombinant |
|||
rAP-0116 | Angio Proteomie | Inquiry | Ask for price |
Mouse Monoclonal anti-human CXCL14 (BRAK) |
|||
hAP-0213 | Angio Proteomie | 100ug | EUR 250 |
Sheep Polyclonal anti-Human CXCL14 (BRAK) |
|||
hAP-5820 | Angio Proteomie | 50ug | EUR 400 |
Anti-Human BRAK Rabbit Polyclonal Antibody |
|||
TA328274 | Origene Technologies GmbH | 100 µg | Ask for price |
BRAK |
|||
chm-001 | ProSpec Tany | 5µg | EUR 60 |
Description: Recombinant Human BRAK (CXCL14) |
BRAK antibody |
|||
70R-BR016 | Fitzgerald | 50 ug | EUR 312 |
|
|||
Description: Affinity purified Rabbit polyclonal BRAK antibody |
Human CXCL14/BRAK ELISA Kit |
|||
E16HE0215 | EnoGene | 96T | EUR 833.33 |
Human BRAK (CXCL14) Recombinant Protein |
|||
100-139 | ReliaTech | 20 µg | EUR 196.35 |
Description: Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 alpha and beta. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues. |
Human BRAK (CXCL14) Recombinant Protein |
|||
100-139S | ReliaTech | 5 µg | EUR 92.4 |
Description: Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 alpha and beta. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues. |
Recombinant Human BRAK (CXCL14) Protein |
|||
PROTO95715-2 | BosterBio | 20ug | EUR 380.4 |
Description: Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 α and β. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues. |
Recombinant Human CXCL14/BRAK Protein |
|||
E40KMP1499 | EnoGene | 20ug | EUR 495 |
Recombinant Human CXCL14/BRAK Protein |
|||
RP00348 | Abclonal | 10 μg | EUR 1137.5 |
|
BRAK (CXCL14) Human Recombinant Protein |
|||
PROTO95715 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: CXCL14 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 77 amino acids and having a molecular mass of 9.4kDa.;The CXCL14 is purified by proprietary chromatographic techniques. |
Human BRAK Recombinant Protein Lyophilized |
|||
IHUBRAKRLY5UG | Innovative research | each | EUR 341 |
|
|||
Description: Human BRAK Recombinant Protein Lyophilized |
Biotinylated Anti-Human BRAK Rabbit Polyclonal Antibody |
|||
TA328273 | Origene Technologies GmbH | 50 µg | Ask for price |
BRAK His |
|||
chm-239 | ProSpec Tany | 1µg | EUR 60 |
Description: Recombinant Human BRAK (CXCL14), His Tag |
Recombinant Human BRAK (CXCL14), His Tag |
|||
7-01780 | CHI Scientific | 5µg | Ask for price |
Recombinant Human BRAK (CXCL14), His Tag |
|||
7-01781 | CHI Scientific | 20µg | Ask for price |
Recombinant Human BRAK (CXCL14), His Tag |
|||
7-01782 | CHI Scientific | 1mg | Ask for price |
BRAK protein |
|||
30R-AB037 | Fitzgerald | 20 ug | EUR 312 |
|
|||
Description: Human recombinant BRAK protein |
BRAK Human Recombinant (CXCL14), His-Tag |
|||
rAP-0119 | Angio Proteomie | Inquiry | Ask for price |
Nori® Human CXCL14/BRAK ELISA Kit |
|||
GR106314 | Genorise Scientific | 96-well | EUR 461 |
Human BRAK Flow Cytometry Assay - Group 6 |
|||
HX87213 | Antigenix America | 96 Tests | EUR 270 |
Recombinant Human BRAK Protein, His, E.coli-1ug |
|||
QP11201-1ug | EnQuireBio | 1ug | EUR 186 |
Recombinant Human BRAK Protein, His, E.coli-5ug |
|||
QP11201-5ug | EnQuireBio | 5ug | EUR 241.2 |
Recombinant Human BRAK Protein, His, E.coli-50ug |
|||
QP11201-50ug | EnQuireBio | 50ug | EUR 1513.2 |
Human, BRAK Human Recombinant Protein (CXCL14), His-Tag |
|||
PROTO95715-1 | BosterBio | Regular: 5ug | EUR 380.4 |
Description: CXCL14 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 88 amino acids and having a molecular mass of 10.66 kDa. ;The Human BRAK contains a 10 a.a. fusion His tag at N-Terminus. ;The BRAK is purified by proprietary chromatographic techniques. |
Recombinant Human BRAK Protein, Untagged, E.coli-1mg |
|||
QP10538-1mg | EnQuireBio | 1mg | EUR 3308.4 |
Recombinant Human BRAK Protein, Untagged, E.coli-5ug |
|||
QP10538-5ug | EnQuireBio | 5ug | EUR 186 |
Recombinant Human BRAK Protein, Untagged, E.coli-20ug |
|||
QP10538-20ug | EnQuireBio | 20ug | EUR 241.2 |
BRAK Recombinant Protein |
|||
40-401-0005mg | ProSci | 0.005 mg | EUR 311.1 |
Description: Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 alpha and beta. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues. |
BRAK Recombinant Protein |
|||
40-401-002mg | ProSci | 0.02 mg | EUR 437.1 |
Description: Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 alpha and beta. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues. |
Rat BRAK ELISA Kit |
|||
ERB0616 | Abclonal | 96Tests | EUR 625.2 |
Goat BRAK ELISA Kit |
|||
EGTB0616 | Abclonal | 96Tests | EUR 625.2 |
Mouse BRAK ELISA Kit |
|||
EMB0616 | Abclonal | 96Tests | EUR 625.2 |
Sheep BRAK ELISA Kit |
|||
ESB0616 | Abclonal | 96Tests | EUR 625.2 |
Breast And Kidney Expressed Chemokine (BRAK) Polyclonal Antibody (Human) |
|||
4-PAB607Hu01 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Breast And Kidney Expressed Chemokine (BRAK) |
Rabbit BRAK ELISA Kit |
|||
ERTB0616 | Abclonal | 96Tests | EUR 625.2 |
Monkey BRAK ELISA Kit |
|||
EMKB0616 | Abclonal | 96Tests | EUR 625.2 |
Canine BRAK ELISA Kit |
|||
ECB0616 | Abclonal | 96Tests | EUR 625.2 |
Bovine BRAK ELISA Kit |
|||
EBB0616 | Abclonal | 96Tests | EUR 625.2 |
Porcine BRAK ELISA Kit |
|||
EPB0616 | Abclonal | 96Tests | EUR 625.2 |
Chicken BRAK ELISA Kit |
|||
ECKB0616 | Abclonal | 96Tests | EUR 625.2 |
Human Breast And Kidney Expressed Chemokine (BRAK) Protein |
|||
20-abx168163 | Abbexa |
|
|
|
Anserine BRAK ELISA Kit |
|||
EAB0616 | Abclonal | 96Tests | EUR 625.2 |
BRAK, CXCL14, murine (mouse) |
|||
RC332-25 | Bio Basic | 5ug | EUR 125.26 |
|
Human BRAK(Breast And Kidney Expressed Chemokine) ELISA Kit |
|||
ELK2082-48T | ELK Biotech | 48T | Ask for price |
|
|||
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human BRAK. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human BRAK. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human BRAK, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human BRAK in the samples is then determined by comparing the OD of the samples to the standard curve. |
Human BRAK(Breast And Kidney Expressed Chemokine) ELISA Kit |
|||
ELK2082-96T | ELK Biotech | 96T | Ask for price |
|
|||
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human BRAK. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human BRAK. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human BRAK, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human BRAK in the samples is then determined by comparing the OD of the samples to the standard curve. |
Recombinant Rat BRAK/CXCL14 |
|||
RECXP-1401 | Cyagen | 5ug | Ask for price |
BRAK (CXCL14) Rat Recombinant |
|||
rAP-0118 | Angio Proteomie | Inquiry | Ask for price |
OOPA00002-5UG - BRAK Protein |
|||
OOPA00002-5UG | Aviva Systems Biology | 5ug | EUR 70 |
|
OPPA01591-5UG - BRAK Protein |
|||
OPPA01591-5UG | Aviva Systems Biology | 5ug | EUR 154 |
|
BRAK (CXCL14) Mouse Recombinant |
|||
rAP-0117 | Angio Proteomie | Inquiry | Ask for price |
Breast And Kidney Expressed Chemokine (BRAK) Polyclonal Antibody (Human), APC |
|||
4-PAB607Hu01-APC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Breast And Kidney Expressed Chemokine (BRAK). This antibody is labeled with APC. |
Breast And Kidney Expressed Chemokine (BRAK) Polyclonal Antibody (Human), Cy3 |
|||
4-PAB607Hu01-Cy3 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Breast And Kidney Expressed Chemokine (BRAK). This antibody is labeled with Cy3. |
Breast And Kidney Expressed Chemokine (BRAK) Polyclonal Antibody (Human), HRP |
|||
4-PAB607Hu01-HRP | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Breast And Kidney Expressed Chemokine (BRAK). This antibody is labeled with HRP. |
Breast And Kidney Expressed Chemokine (BRAK) Polyclonal Antibody (Human), PE |
|||
4-PAB607Hu01-PE | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Breast And Kidney Expressed Chemokine (BRAK). This antibody is labeled with PE. |
Recombinant Murine BRAK/CXCL14 |
|||
MECXP-1401 | Cyagen | 5ug | Ask for price |
Human Breast And Kidney Expressed Chemokine (BRAK) CLIA Kit |
|||
20-abx190238 | Abbexa |
|
|
|
Human Breast And Kidney Expressed Chemokine (BRAK)CLIA Kit |
|||
SCB607Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 6777.36 |
|
|||
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Breast And Kidney Expressed Chemokine (BRAK) in serum, plasma and other biological fluids. |
Human Breast And Kidney Expressed Chemokine (BRAK)CLIA Kit |
|||
SCB607Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 663.31 |
|
|||
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Breast And Kidney Expressed Chemokine (BRAK) in serum, plasma and other biological fluids. |
Human Breast And Kidney Expressed Chemokine (BRAK)CLIA Kit |
|||
SCB607Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 896.16 |
|
|||
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Breast And Kidney Expressed Chemokine (BRAK) in serum, plasma and other biological fluids. |
Human Breast And Kidney Expressed Chemokine (BRAK)CLIA Kit |
|||
SCB607Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3672.72 |
|
|||
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Breast And Kidney Expressed Chemokine (BRAK) in serum, plasma and other biological fluids. |
Human Breast And Kidney Expressed Chemokine (BRAK) CLIA Kit |
|||
4-SCB607Hu | Cloud-Clone |
|
|
|
|||
Description: Double-antibody Sandwich chemiluminescent immunoassay for detection of Human Breast And Kidney Expressed Chemokine (BRAK)Serum, plasma and other biological fluids |
Breast And Kidney Expressed Chemokine (BRAK) Polyclonal Antibody (Human), FITC |
|||
4-PAB607Hu01-FITC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Breast And Kidney Expressed Chemokine (BRAK). This antibody is labeled with FITC. |
Human Breast and kidney expressed chemokine,BRAK ELISA Kit |
|||
201-12-0062 | SunredBio | 96 tests | EUR 528 |
|
|||
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Breast And Kidney Expressed Chemokine (BRAK) ELISA Kit |
|||
DLR-BRAK-Hu | DL Develop | 96T | EUR 443 |
|
|||
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Breast And Kidney Expressed Chemokine (BRAK) ELISA Kit |
|||
DLR-BRAK-Hu-48T | DL Develop | 48T | EUR 597.6 |
|
|||
Description: A sandwich quantitative ELISA assay kit for detection of Human Breast And Kidney Expressed Chemokine (BRAK) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Breast And Kidney Expressed Chemokine (BRAK) ELISA Kit |
|||
DLR-BRAK-Hu-96T | DL Develop | 96T | EUR 776.4 |
|
|||
Description: A sandwich quantitative ELISA assay kit for detection of Human Breast And Kidney Expressed Chemokine (BRAK) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Breast and kidney expressed chemokine(BRAK) Elisa Kit |
|||
EK700372 | AFG Bioscience LLC | 96 Wells | EUR 0.35 |
Human Breast and kidney expressed chemokine,BRAK ELISA Kit |
|||
EKC40727-48T | Biomatik Corporation | 48T | EUR 597.24 |
Human Breast and kidney expressed chemokine,BRAK ELISA Kit |
|||
EKC40727-5x96T | Biomatik Corporation | 5x96T | EUR 4052.7 |
Human Breast and kidney expressed chemokine,BRAK ELISA Kit |
|||
EKC40727-96T | Biomatik Corporation | 96T | EUR 853.2 |
Human Breast And Kidney Expressed Chemokine (BRAK) ELISA Kit |
|||
EKL55886-5x96T | Biomatik Corporation | 5x96T | EUR 3622.83 |
Human Breast And Kidney Expressed Chemokine (BRAK) ELISA Kit |
|||
EKL55886-96T | Biomatik Corporation | 96T | EUR 762.7 |
Human Breast and kidney expressed chemokine(BRAK)ELISA Kit |
|||
GA-E0101HM-48T | GenAsia Biotech | 48T | EUR 346.8 |